Skip to main content
Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
China flag China · Delayed Price · Currency is CNY
50.49
-0.14 (-0.28%)
At close: Nov 13, 2026

Hangzhou AGS MedTech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
187.84221.71293.39217.24144.96104.8
Depreciation & Amortization
12.9513.279.176.566.264.4
Other Amortization
3.192.870.881.141.441.96
Loss (Gain) From Sale of Assets
0.050.050.190.350.140.01
Asset Writedown & Restructuring Costs
0.250.250.020.461.961.01
Loss (Gain) From Sale of Investments
-39.48-39.48-21.63-2.117.19-1.72
Provision & Write-off of Bad Debts
0.280.28-0.52.15--
Other Operating Activities
91.778.111.461.81-11.534.73
Change in Accounts Receivable
10.0810.089.42-39.77-8.190.08
Change in Inventory
-9.17-9.17-13.61-12.67-1.28-22.19
Change in Accounts Payable
-54.44-54.4432.4445.4415.725.06
Change in Other Net Operating Assets
-1.43-1.433.912.4--
Operating Cash Flow
200.99151.2315.8221.45156.38118.25
Operating Cash Flow Growth
-8.16%-52.12%42.60%41.61%32.24%121.61%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-55.45-63.47-49.6-51.57-60.12-15.66
Sale of Property, Plant & Equipment
0.450.50.040.080.030
Investment in Securities
118.62118.62-1,081-25.3-55-
Other Investing Activities
-278.39-141.26---3.510.37
Investing Cash Flow
-214.77-85.6-1,130-76.79-118.6-15.29

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-35----
Total Debt Issued
13735----
Long-Term Debt Repaid
--1.31-0.85-1.18-1.52-0.67
Lease Payments
-1.31-1.31-0.85-1.18-1.52-0.67
Total Debt Repaid
-86.31-1.31-0.85-1.18-1.52-0.67
Net Debt Issued (Repaid)
50.6933.69-0.85-1.18-1.52-0.67
Issuance of Common Stock
12.2619.395.871,820--
Repurchase of Common Stock
--0.32-30.97---
Common Dividends Paid
-83.68-111.2-83.33-43.98-35.95-49.05
Other Financing Activities
-25.822--177.6-1.15-
Financing Cash Flow
-46.56-56.43-109.281,598-38.62-49.72

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-17.08-4.490.320.659.45-4.75
Net Cash Flow
-77.424.68-923.511,7438.6248.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
145.5487.74266.19169.8896.26102.59
Free Cash Flow Growth
-2.69%-67.04%56.70%76.48%-6.17%308.62%
Free Cash Flow Margin
26.58%14.78%41.81%33.39%25.94%33.59%
Free Cash Flow Per Share
1.811.093.302.341.581.69
Levered Free Cash Flow
-200.2139.93159.9679.6956.7368.87
Unlevered Free Cash Flow
-200.214016079.6956.7368.87
Free Cash Flow After Leases
144.2386.43265.34168.794.74101.92

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
56.1672.872.4542.1819.7317.57
Change in Working Capital
-55.86-55.8632.83-6.155.963.07